Back to Mobile View

byetta

Pharmaceutical giant Eli Lilly -- maker of Prozac and Cialis -- is expected to post solid fourth-quarter profits on Thursday after a recent restructuring. But the results will likely be lower than the year-ago quarter.
Federal regulators approved Novo Nordisk's new once-daily injection for treating Type 2 diabetes Victoza, driving shares higher. Shares of Amylin Pharmaceuticals also rallied as the approval of Victoza raises hopes that Amylin's rival drug will also get the greenlight.
The U.S. diabetes drug market just got a little more competitive. Swiss drugmaker Roche (RHHBY) said Wednesday an experimental medicine in late-stage development works better in treating type 2 diabetes than Merck (MRK) Januvia, according to a clinical study.

Market Movers

SymbolLastChange / %Volume

Most Actives

BAC
Bank of America Corp
8.10-0.09
-1.04%
158.19M
ALU
Alcatel-Lucent (ADR)
2.20+0.26
+13.14%
95.52M
GE
General Electric Company
18.90-0.24
-1.23%
26.45M
F
Ford
12.41-0.28
-2.21%
25.99M

% Gainers

CIE
Cobalt International Energy
32.62 +8.72
+36.49%
14.25M
LNKD
LinkedIn Corp.
89.53 +13.14
+17.20%
9.05M
ALU
Alcatel-Lucent (ADR)
2.20 +0.26
+13.14%
95.52M
WNS
WNS (Holdings) Limited (ADR)
10.52 +1.12
+11.91%
2.68M

% Losers

KV-A
K V Pharmaceutical Co. Class A
2.10-0.51
-19.54%
1.45M
KV-B
K-V Pharmaceutical Co. Class B
2.16-0.47
-17.87%
4,779
NBG-A
National Bank of Greece SA (ADR)
5.74-1.01
-14.96%
125,314
OSG
Overseas Shipholding Group, Inc.
10.43-1.40
-11.83%
1.35M
Newswire

Follow Us

Headlines From DailyFinance Partners

CNN Money
CNBC
Smart Money
Consumer Reports
Huffington Post
AOL Energy
AOL Jobs
Business News Personal Finance Investing Our Partners

DailyFinance Sitemap | Terms of Service | Privacy Policy | Trademarks | HELP | Advertise With Us

© Copyright 2012 AOL Inc. All Rights Reserved